Document is current

Article History

Received: 21 October 2020

Accepted: 26 August 2021

First Online: 3 September 2021

Declarations

:

: The study was approved by the Ethics Committee of Cancer Institute Hospital, Japanese Foundation for Cancer Research prior to initiation (approval number: 2019–1018). All procedures were in accordance with the 1964 Declaration of Helsinki and its later amendments or with comparable ethical standards. Informed consent for this retrospective, noninvasive study was not required by the local ethics committee. The local ethics committee permitted to access the raw data from the hospital database.

: Not applicable.

: SH has received honoraria from MSD, Shionogi, Astellas, BD, Beckman Coulter Diagnostics, Sumitomo Dainippon Pharma, and Meiji; has served in a consultancy<b>/</b>advisory role for FUJIFILM Toyama Chemical; and has received research funding from MSD, outside the submitted work. BH has received honoraria from Janssen Pharmaceutica, outside the submitted work. DO has received Honoraria from Sumitomo Dainippon, outside the submitted work. All other authors have no conflicts of interest to declare.